Medicare told to reassess premium hike for Alzheimer’s drug

22 articles, oldest first.

1. The Columbian

   Medicare told to reassess premium hike for Alzheimer’s drug ↗ (opens The Columbian)

   Published Jan 9, 2022

   Same headline from 18 more outlets

   The Columbian's feed description

   WASHINGTON — U.S. health secretary Xavier Becerra on Monday ordered Medicare to reassess a big premium increase facing millions of seniors this year, attributed in large part to a pricey new Alzheimer

2. Fox News

   HHS Secretary Becerra orders Medicare to reassess premium hike on new Alzheimer's drug ↗ (opens Fox News)

   Published Jan 9, 2022

   Fox News's feed description

   U.S. health secretary Xavier Becerra on Monday ordered Medicare to reassess a big premium increase facing millions of seniors this year, attributed in large part to a pricey new Alzheimer's drug with questionable benefits.

3. FOX Business

   Medicare told to reassess premium hike after price slashed on Biogen Alzheimer's drug ↗ (opens FOX Business)

   Published Jan 9, 2022

   FOX Business's feed description

   Department of Health and Human Services Secretary Xavier Becerra has asked Medicare to reassess its 2022 premium increase after Biogen slashed the cost of its expensive new Alzheimer's drug, which was part of the reason for the boost.

4. The Hill

   HHS secretary orders Medicare to 'reassess' premium increase driven by Alzheimer's drug ↗ (opens The Hill)

   Published Jan 9, 2022

   The Hill's feed description

   Secretary of Health and Human Services (HHS) Xavier Becerra on Monday ordered Medicare to “reassess” a proposed premium increase after an expensive new Alzheimer’s drug fell in price.

Identical headlines usually mean shared wire copy. They are counted as separate articles but are not independent confirmation.